deltatrials
Recruiting NA INTERVENTIONAL 2-arm NCT06882824

Prevention of HEMOrhagic Risk in Upper MYOmeCTomy by Use of Misoprostol. (HEMOMYOC)

Sponsor: University Hospital, Clermont-Ferrand

Conditions Myoma;Uterus Myomectomy; Surgical Blood Loss
Interventions myomectomy with misoprostol myomectomy with placebo
Updated 2 times since 2025 Last updated: Sep 19, 2025 Started: Mar 12, 2025 Primary completion: Apr 17, 2027 Completion: Apr 17, 2028
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06882824, this NA trial focuses on Myoma;Uterus and Myomectomy; Surgical Blood Loss and remains actively recruiting participants. Sponsored by University Hospital, Clermont-Ferrand, it has been updated 2 times since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Apr 2025 – ~Oct 2025 · 6 months · monthly snapshotNot Yet Recruiting~Oct 2025 – present · 11 months · monthly snapshotRecruiting

Change History

2 versions recorded

  1. Oct 2025 — Present [monthly]

    Recruiting NA

    Status: Not Yet Recruiting → Recruiting

  2. Apr 2025 — Oct 2025 [monthly]

    Not Yet Recruiting NA

    First recorded

Mar 2025

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University Hospital, Clermont-Ferrand
Data source: University Hospital, Clermont-Ferrand

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations